6BORJESSON P K, POSTEMA E J, ROOS J C, et al. Phase I therapy study with ^186Re-labeled humanized monoclonal antibody BIWA 4(bivatuzumab)in patients with head and neck squamous cell carcinoma [J]. Clin Cancer Res,2003,9(2) :3 961-3 972.
7VEREL I, VISSER G W, BOELLAARD R, et al. Quantitative ^89Zr immuno-PET for in vivo scouting of ^90Y-labeled monoclonal antibodies in xenograft-bearing nude mice [J] .J Nucl Med,2003,44(10) :1 663-1 670.
8WAHL R L. The clinical imlaortance of dosimetry in radioimmunotherapy with tositumomab and iodine I^131 tositumomab[J ]. Semin Oncol,2003,30(4) :31-38.
9DAVISC. Transgenicmice as a source of fully human antibodies for the treatment of cancer [J ]. Cancer Metastasis Rev,1999,18(4) :421-425.
10YANG X D. Fully humanati inter leukin 8 monoclonal antibodies: Potential the repeutics for the treatment of in flammatory disease states [J] .J Leukoc Bio1,1999,66(3) :401-410.
